We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Sofosbuvir

Australian Public Assessment Report

AusPAR

AusPAR: Sofosbuvir [PDF, 2.25 MB]

AusPAR: Sofosbuvir [Word, 2.86 MB]

Attachment: Product Information: Sofosbuvir [PDF, 510.67 KB]

Attachment: Product Information: Sofosbuvir [Word, 280.29 KB]

Attachment: Extract from Clinical Evaluation Report: Sofosbuvir [PDF, 5.75 MB]

Attachment: Extract from Clinical Evaluation Report: Sofosbuvir [Word, 6.18 MB]

Device/Product Name

Sovaldi

Active ingredients

Sofosbuvir

AusPAR Date

5 August 2014

Published

1 September 2014

Submission Number

PM-2013-01283-1-2

Submission Type

New chemical entity

Decision

Approved